Stocks and Investing Stocks and Investing
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017

Michael Yee Initiated (VRTX) at Buy and Held Target at $175 on, Sep 15th, 2017


Published on 2024-10-25 22:50:23 - WOPRAI, Michael Yee
  Print publication without navigation


Michael Yee of RBC Capital, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $175 on, Sep 15th, 2017.

Michael has made no other calls on VRTX in the last 4 months.



There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 0 agree with Michael's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Michael


  • Christopher Raymond of "Raymond James" Upgraded from Hold to Buy on, Wednesday, July 19th, 2017
  • Debjit Chattopadhyay of "Janney Montgomery Scott" Upgraded from Hold to Strong Buy on, Wednesday, July 19th, 2017
  • Geoff Meacham of "Barclays" Upgraded from Hold to Buy on, Wednesday, July 19th, 2017
  • Phil Nadeau of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, July 19th, 2017
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, July 19th, 2017
  • Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $155 on, Tuesday, July 11th, 2017
  • Alan Carr of "Needham" Upgraded from Hold to Strong Buy on, Friday, June 23rd, 2017
  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy on, Friday, June 2nd, 2017